24 HIGHER SUSTAINED VIROLOGIC RESPONSE AND HISTOLOGIC IMPROVEMENT IN RECURRENT HEPATITIS C AFTER PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY UNDER CYCLOSPORINE-BASED VERSUS TACROLIMUS-BASED IMMUNOSUPPRESSIVE THERAPY

24 HIGHER SUSTAINED VIROLOGIC RESPONSE AND HISTOLOGIC IMPROVEMENT IN RECURRENT HEPATITIS C AFTER PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY UNDER CYCLOSPORINE-BASED VERSUS TACROLIMUS-BASED IMMUNOSUPPRESSIVE THERAPY M. Navasa, T. Casanovas, M. Berenguer, I. Fernandez, M. Salcedo, L. Castells, J. Pascasio, J. Fernandez, I. Herrero, A. Otero, S. Tome, M. de la Mata, R. Barcena, I. Banos, M. Guilera, on behalf of ReViS-TC Study Group. Hospital Clinic i Provincial, Barcelona, Hospital de Bellvitge, L’Hospitalet de Llobregat, Hospital La Fe, Valencia, Hospital 12 de Octubre, Hospital Gregorio Maranon, Madrid, Hospital Vall d’Hebron, Barcelona, Hospital Virgen del Rocio, Sevilla, Hospital de Cruces, Bilbao, Cĺinica Universitaria Navarra, Pamplona, Hospital Juan Canalejo, A Coruna, Hospital Santiago, Santiago de Compostela, Hospital Reina Sofia, Cordoba, Hospital Ramon y Cajal, Hospital Puerta Hierro, Madrid, Novartis Farmaceutica, S.A., Barcelona, Spain E-mail: teresacasanovas@bellvitgehospital.cat